Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
- PMID: 33150525
- PMCID: PMC7641257
- DOI: 10.1186/s13613-020-00769-2
Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome
Abstract
Background: In COVID-19 patients with severe acute respiratory distress syndrome (ARDS), the relatively preserved respiratory system compliance despite severe hypoxemia, with specific pulmonary vascular dysfunction, suggests a possible hemodynamic mechanism for VA/Q mismatch, as hypoxic vasoconstriction alteration. This study aimed to evaluate the capacity of inhaled nitric oxide (iNO)-almitrine combination to restore oxygenation in severe COVID-19 ARDS (C-ARDS) patients.
Methods: We conducted a monocentric preliminary pilot study in intubated patients with severe C-ARDS. Respiratory mechanics was assessed after a prone session. Then, patients received iNO (10 ppm) alone and in association with almitrine (10 μg/kg/min) during 30 min in each step. Echocardiographic and blood gases measurements were performed at baseline, during iNO alone, and iNO-almitrine combination. The primary endpoint was the variation of oxygenation (PaO2/FiO2 ratio).
Results: Ten severe C-ARDS patients were assessed (7 males and 3 females), with a median age of 60 [52-72] years. Combination of iNO and almitrine outperformed iNO alone for oxygenation improvement. The median of PaO2/FiO2 ratio varied from 102 [89-134] mmHg at baseline, to 124 [108-146] mmHg after iNO (p = 0.13) and 180 [132-206] mmHg after iNO and almitrine (p < 0.01). We found no correlation between the increase in oxygenation caused by iNO-almitrine combination and that caused by proning.
Conclusion: In this pilot study of severe C-ARDS patients, iNO-almitrine combination was associated with rapid and significant improvement of oxygenation. These findings highlight the role of pulmonary vascular function in COVID-19 pathophysiology.
Keywords: ARDS; Almitrine; COVID-19; iNO.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19.Front Med (Lausanne). 2021 Jul 1;8:655763. doi: 10.3389/fmed.2021.655763. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34277653 Free PMC article.
-
Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome.Crit Care Med. 1997 May;25(5):786-94. doi: 10.1097/00003246-199705000-00013. Crit Care Med. 1997. PMID: 9187597 Clinical Trial.
-
Efficacy of almitrine as a rescue therapy for refractory hypoxemia in COVID and non-COVID acute respiratory distress syndrome. A retrospective monocenter study.Minerva Anestesiol. 2023 Mar;89(3):157-165. doi: 10.23736/S0375-9393.22.16736-2. Epub 2022 Oct 26. Minerva Anestesiol. 2023. PMID: 36287391
-
Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications.J Aerosol Med Pulm Drug Deliv. 2023 Jun;36(3):112-126. doi: 10.1089/jamp.2022.0058. Epub 2023 Apr 20. J Aerosol Med Pulm Drug Deliv. 2023. PMID: 37083488 Free PMC article. Review.
-
The role of inhaled prostacyclin in treating acute respiratory distress syndrome.Ther Adv Respir Dis. 2015 Dec;9(6):302-12. doi: 10.1177/1753465815599345. Epub 2015 Aug 20. Ther Adv Respir Dis. 2015. PMID: 26294418 Review.
Cited by
-
The Potential Role of Nitric Oxide as a Therapeutic Agent against SARS-CoV-2 Infection.Int J Mol Sci. 2023 Dec 5;24(24):17162. doi: 10.3390/ijms242417162. Int J Mol Sci. 2023. PMID: 38138990 Free PMC article. Review.
-
Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.Indian J Pharmacol. 2021 May-Jun;53(3):236-243. doi: 10.4103/ijp.ijp_382_21. Indian J Pharmacol. 2021. PMID: 34169911 Free PMC article.
-
Inhaled nitric oxide in moderate-to-severe COVID-19 acute respiratory distress syndrome: a retrospective cohort study.Einstein (Sao Paulo). 2024 Aug 16;22:eAO0578. doi: 10.31744/einstein_journal/2024AO0578. eCollection 2024. Einstein (Sao Paulo). 2024. PMID: 39166698 Free PMC article.
-
Use of almitrine in spontaneously breathing patients with COVID-19 treated with high-flow nasal cannula oxygen therapy and with persistent hypoxemia.Respir Res. 2023 Jan 5;24(1):1. doi: 10.1186/s12931-022-02308-y. Respir Res. 2023. PMID: 36600234 Free PMC article.
-
Respiratory system mechanics, gas exchange, and outcomes in mechanically ventilated patients with COVID-19-related acute respiratory distress syndrome: a systematic review and meta-analysis.Lancet Respir Med. 2022 Dec;10(12):1178-1188. doi: 10.1016/S2213-2600(22)00393-9. Epub 2022 Nov 3. Lancet Respir Med. 2022. PMID: 36335956 Free PMC article.
References
-
- DellaVolpe J, Barbaro RP, Cannon JW, Fan E, Greene WR, Gunnerson KJ, et al. Joint society of critical care medicine-extracorporeal life support organization task force position paper on the role of the intensivist in the initiation and management of extracorporeal membrane oxygenation. Crit Care Med. 2020;48:838–846. doi: 10.1097/CCM.0000000000004330. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources